Vimseltinib
Vimseltinib (DCC-3014) is a potent small molecule inhibitor targeting c-FMS (CSF-1R) and c-Kit with IC50 values of <0.01 μM and 0.1-1 μM, respectively. It is utilized in research exploring tumor-associated macrophages and has demonstrated activity in both in vitro cellular assays and in vivo models of tenosynovial giant cell tumor.
Product Specifications
CAS Number
1628606-05-2
Product Name Alternative
Inhibit, DCC 3014, DCC3014, DCC-3014, Inhibitor, colony stimulating factor 1 receptor, CD117, cFms, c-Fms, c-FMS/CSF-IR, c-Kit, cKit, CSF-1 receptor, CSF1R, CSF-1R, Vimseltinib, SCFR
Field of Research
Signal Transduction
Purity
98.98% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.65 mM) ; DMSO:60 mg/mL (139.05 mM)
Smiles
CC (C) Nc1ncc (-c2ccc (Oc3ccnc (c3) -c3cnn (C) c3) c (C) n2) c (=O) n1C
Molecular Formula
C23H25N7O2
Molecular Weight
431.49
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP70306_P050 100 µL
FAM117B Antibody - C-terminal region (ARP70306_P050)
Sign In for Pricing
View Details 
VUB29470-01 50 mg
5- (4-Bromophenyl) -3- (propan-2-yl) -1,2,4-oxadiazole
Sign In for Pricing
View Details VUB29470-02 0.5 g
5- (4-Bromophenyl) -3- (propan-2-yl) -1,2,4-oxadiazole
Sign In for Pricing
View Details 
OR1082356-01 250 mg
2- (4-Bromo-2-chlorophenyl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Sign In for Pricing
View Details OR1082356-02 500 mg
2- (4-Bromo-2-chlorophenyl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Sign In for Pricing
View Details OR1082356-03 1 g
2- (4-Bromo-2-chlorophenyl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Sign In for Pricing
View Details